A multicenter, randomized, double-blind, safety and efficacy study of H 199/18 with clarithromycin compared to H 199/18 for the eradication of Helicobacter pylori in subjects with active duodenal ulcer or history of duodenal ulcer disease.

Study identifier:SH-QBE-0042

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A multicenter, randomized, double-blind, safety and efficacy study of H 199/18 with clarithromycin compared to H 199/18 for the eradication of Helicobacter pylori in subjects with active duodenal ulcer or history of duodenal ulcer disease.

Medical condition

gastrointestinal diseases

Phase

N/A

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Interventional

Age

Date

Study Start Date: 01 Jan 1971

Primary Completion Date: -

Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

"There is no result for the study"

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=2315&filename=CSR-SH-QBE-0042.pdf
Download
CSR-SH-QBE-0042.pdf
Download
Trial Results Summaries
Available here

A multicenter, randomized, double-blind, safety and efficacy study of H 199/18 with clarithromycin compared to H 199/18 for the eradication of Helicobacter pylori in subjects with active duodenal ulcer or history of duodenal ulcer disease.

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=2315&filename=CSR-SH-QBE-0042.pdf

CSR-SH-QBE-0042.pdf

Trial Results Summaries